Skip to content

Impact of ultrasound assessment on fluid treatment decisions in ICU patients

Does VExUS change the plan? A prospective evaluation of ultrasound-guided fluid management in the ICU - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/06/111576
Enrollment
70
Registered
2026-06-01
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R098- Other specified symptoms and signsinvolving the circulatory and respiratory systems

Interventions

Intervention1: Nil: Nil Intervention2: VExUS assessment: Bedside venous excess ultrasound assessment including IVC diameter, hepatic vein Doppler, portal vein pulsatility and intrarenal venous Doppler

Sponsors

PES Institute of Medical Sciences and Research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Age greater than 18 years 2.ICU patients requiring fluid assessment or resuscitation 3.Hemodynamically stable or stabilized patients 4.Consent obtained from patient or legally authorized representative

Exclusion criteria

Exclusion criteria: 1. Poor acoustic window for ultrasound 2. Severe tricuspid regurgitation 3. Chronic liver disease with altered portal flow 4. End-stage renal disease (ESRD) on dialysis 5. Patients with intra-abdominal hypertension

Design outcomes

Primary

MeasureTime frame
Change in fluid management decision after VExUS assessment in ICU patientsTimepoint: Baseline (before VExUS assessment) and immediately after VExUS assessment

Secondary

MeasureTime frame
Type of management change including fluid bolus, fluid restriction, diuretic therapy or no changeTimepoint: Immediately after VExUS assessment;Correlation between VExUS grade and ICU length of stayTimepoint: At ICU discharge

Countries

India

Contacts

Public ContactDr Alekhya Sai Guntupalli

PES Institute of Medical Sciences and Research

g.alekhyasai@outlook.com9030476936

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 29, 2026